.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Argus Health
Deloitte
QuintilesIMS
Dow
Boehringer Ingelheim
Teva
Moodys
US Army
Colorcon

Generated: July 22, 2017

DrugPatentWatch Database Preview

Ethacrynate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ethacrynate sodium and what is the scope of ethacrynate sodium patent protection?

Ethacrynate sodium
is the generic ingredient in two branded drugs marketed by Mylan Institutional, Par Sterile Products, and Aton, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for ethacrynate sodium. Four suppliers are listed for this compound.

Summary for Generic Name: ethacrynate sodium

Tradenames:2
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list4
Clinical Trials: see list2,360
Patent Applications: see list380
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ethacrynate sodium at DailyMed

Pharmacology for Ingredient: ethacrynate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
EDECRIN
ethacrynate sodium
INJECTABLE;INJECTION016093-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Par Sterile Products
ETHACRYNATE SODIUM
ethacrynate sodium
INJECTABLE;INJECTION205473-001Jul 29, 2015APRXNoNo► Subscribe► Subscribe
Mylan Institutional
ETHACRYNATE SODIUM
ethacrynate sodium
INJECTABLE;INJECTION204634-001Aug 23, 2016APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
McKinsey
Cipla
UBS
Baxter
Chinese Patent Office
US Army
Fuji
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot